-
-
-
Description
Competes with histamines for H1-receptors in blood vessels, respiratory system, and GI tract.
-
Actions
- 1. Decreases vascular permeability and bronchoconstriction secondary to histamine release. 2. Decreases dystonias
- 3. Sedation
- 4. Decreases nausea
-
Indications
- 1. Allergic reactions and anaphylaxis
- 2. Extrapyramidal/Dystonic reactions to anti-psychotics
-
Contraindications
- 1. Hypersensitivity
- 2. Acute asthma attack
- 3. Pregnancy, nursing
- 4. Narrow-angle glaucoma
-
Side Effects
- 1. Drowsiness / sedation (excitement in children) 2. Paradoxical anxiety, and agitation in peds.
- 3. Dry mouth / thickened bronchial secretions
- 4. Anaphylaxis
- 5. Seizures
-
Administration
Adult: 25-50 mg IV/IM/PO, rate 25 mg/min IV Peds: <12 y/o contact base hospital for dosing
-
Onset/duration
Immediate via IV, up to 30 min IM. Duration 4-8 hrs both routes.
|
|